Please complete the CAPTCHA to continue
@alconlabs.com
✓
1 phone found area 656
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Raj Patil, Ph.D. is listed as Chief Scientific Officer at OKYO Pharma leading innovative drug development at OKYO Pharma, based in New York, New York, United States. AeroLeads shows a work email signal at alconlabs.com, phone signal with area code 656, and a matched LinkedIn profile for Raj Patil, Ph.D..
Raj Patil, Ph.D. previously worked as Chief Scientific Officer at Okyo Pharma and Vice President of Research & Development at Ora, Inc.. Raj Patil, Ph.D. holds Postdoctoral Scholar, Biochemistry And Molecular Biology from University Of Michigan.
This section adds company-level context without repeating Raj Patil, Ph.D.'s masked contact details.
AeroLeads found 1 current-domain work email signal for Raj Patil, Ph.D.. Compare company email patterns before reaching out.
At OKYO Pharma, my role as Chief Scientific Officer centers on crafting a scientific vision to cultivate an innovative pipeline targeting ocular disorders, while ensuring alignment with our corporate mission. Our team's success in advancing lead drug candidates through non-clinical and clinical stages is a testament to our strategic partnerships in academia and with industry specialists such as CROs and CDMOs.The journey involves providing scientific leadership and interfacing with key opinion leaders to promote OKYO's groundbreaking work. My expertise in drug discovery and life sciences has been honed by strategically managing OKYO's R&D and contributing to the non-clinical and clinical drug development. This has culminated in a robust approach to tackling sight-threatening eye diseases, leveraging our collective expertise in pharmaceuticals to achieve rapid clinical translation and path to drug registration.
Listed skills include Drug Discovery, Pharmaceutical Industry, Lifesciences, Drug Development, and 46 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Responsible for developing OKYO’s scientific strategy to build a diverse pipeline of novel products targeting ocular disorders and oversee non-clinical and clinical development of lead drug candidates by building partnerships and collaborations with academia and various CROs and CDMOs in order to achieve rapid clinical translation, with a path to.
Andover, Massachusetts, US
Accountable for the global planning, execution, and management of Ora’s R&D Institute.About Ora, Inc.Ora (Ophthalmic Research Associates) is a leading full-service preclinical and clinical ophthalmic drug and device development firm. Over 40 years of global experience has given Ora unparalleled insight into clinical strategy and regulatory requirements.
OKYO Pharma (LSE: OKYO) is a biotechnology company developing first-in-class drug candidates for treatment of sight-threatening eye diseases and non-opioid analgesics.
Salt Lake City, UT, US
Existing therapies rely on drops or injections to deliver medicine, and often do not reach the retina or the inside of cells. iVeena uses novel approaches — including drug delivery from the lens capsule, minimally invasive implants, and intracellular therapy — to reach target tissues for better patient outcomes.
Singapore, Singapore, SG
Dept of Ophthalmology & Visual Sciences Academic Clinical ProgramEngaged in integrating the clinical and discovery expertise to create a unique platform for biomarker/target identification and drug repurposing for retinal diseases in partnership with pharmaceutical industries.
Basel, Baselstadt, CH
Identified novel preclinical targets for retinal diseases and established project teams to identify lead candidates. Managed and allocated resources needed to achieve group objectives including budgeting and capital expenses and implemented required technologies. Led and collaborated with multidisciplinary project teams of in vitro/in vivo biologists.
Geneva, Switzerland, CH
Managed and executed several academic/industry biomedical research collaborations. Led a team of 6-8 scientists (PhD, MS, BS) focused on advancing the preclinical candidates (small molecules, siRNA and biologics) to clinical development. Established in vitro and in vivo models, and evaluated preclinical candidates. Executed planning, organizing and.
Omaha, Nebraska, US
Dept of Ophthalmology & Visual SciencesResearch Interest: Glaucoma, AMD and Diabetic Retinopathy
St. Louis, MO, US
Dept of Ophthalmology & Visual SciencesResearch Interest: Glaucoma, Retina, Pharmacology, Physiology
Quick answers generated from the profile data available on this page.
Raj Patil, Ph.D. works for OKYO Pharma.
Raj Patil, Ph.D. is listed as Chief Scientific Officer at OKYO Pharma leading innovative drug development at OKYO Pharma.
AeroLeads has found 1 work email signal at @alconlabs.com for Raj Patil, Ph.D. at OKYO Pharma.
AeroLeads has found 1 phone signal(s) with area code 656 for Raj Patil, Ph.D. at OKYO Pharma.
Raj Patil, Ph.D. is based in New York, New York, United States while working with OKYO Pharma.
Raj Patil, Ph.D. has worked for Okyo Pharma, Ora, Inc., Iveena, Duke-Nus Medical School, and Novartis Institutes For Biomedical Research.
You can use AeroLeads to view verified contact signals for Raj Patil, Ph.D. at OKYO Pharma, including work email, phone, and LinkedIn data when available.
Raj Patil, Ph.D. holds Postdoctoral Scholar, Biochemistry And Molecular Biology from University Of Michigan.
Raj Patil, Ph.D. is listed with skills including Drug Discovery, Pharmaceutical Industry, Lifesciences, Drug Development, Target Identification, Communication, Team Building, and Team Leadership.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts